Healthcare Finance News August 5, 2024
Nearly 10% of the U.S. population will be using GLP-1s in the next 10 years or sooner, Cigna CEO David Cordani says.
Cigna’s profits increased to $1.9 billion during the second quarter of 2024, compared with $1.8 billion during the same quarter in 2023, according to the company’s earnings report released Aug. 1.
The growing specialty pharmacy business is one reason for the increase.
Specialty and Care Services showed strong growth with revenue up 18% to $22.9 billion, and pre-tax adjusted earnings were up 12% to $756 million, at the high end of the company’s long-term target growth range, said Brian Evanko, CFO and president and CEO Cigna Healthcare.
On Thursday’s earnings call, Chairman and CEO David Cordani talked about...
Today's Sponsors
Today's Sponsor